Pharmacovigilance in the Age of Legalized Cannabis: Using Social Media to Monitor Drug–Drug Interactions Between Immunosuppressants and Cannabis-Derived Products

Ayers, John W.
DOI: https://doi.org/10.1007/s40264-024-01481-x
2024-09-20
Drug Safety
Abstract:A clinical trial of Epidiolex ® , the only US FDA-approved cannabis-derived consumer product (CDP), discovered an interaction with an immunosuppressant (tacrolimus) that led to drug toxicity, highlighting the unique intersection of prescription and commonly unregulated consumer products.
pharmacology & pharmacy,public, environmental & occupational health,toxicology
What problem does this paper attempt to address?